The adult mammalian heart has little regenerative capacity after myocardial infarction (MI), whereas neonatal mouse heart regenerates without scarring or dysfunction. However, the underlying pathways are poorly defined. We sought to derive insights into the pathways regulating neonatal development of the mouse heart and cardiac regeneration post-MI.
H
eart disease is among the commonest causes of death worldwide. 1 While planarians, teleost fish, and some amphibians have the ability to regrow limbs or organs including the heart, 2-4 mammals are limited in their regenerative abilities. 5, 6 After myocardial infarction (MI), damaged myocardium is replaced by scar tissue triggering cardiac remodeling and impaired cardiac function. 7, 8 A major barrier to cardiac regeneration in adult mammals is the withdrawal of the cardiomyocyte from the cell cycle in early postnatal life. In the mouse, although DNA replication continues in the first week of postnatal life, cytokinesis ceases. By the second week of life, mouse cardiomyocytes withdraw from the cell cycle, 90% of cardiomyocytes are binucleated and, aside from a recent report of a proliferative burst at P15, 9 recently contested, 10 heart growth after the first week of life occurs mainly through cardiomyocyte hypertrophy rather than proliferation. 11, 12 This program of cell cycle arrest is hypothesized to result from metabolic, physiological, and anatomic changes in the first week of life including a shift to oxidative metabolism with relative hyperoxia compared with fetal life, increasing ventricular pressure and accumulation of extracellular matrix. 13 These considerations raised the possibility that regeneration of the mouse heart could follow cardiac injury in the immediate neonatal period and indeed complete cardiac regeneration has recently been demonstrated after apex resection and infarction of the mouse left ventricle (LV) on the first day of postnatal life. [14] [15] [16] Transcriptome analyses in planarians and amphibians have yielded significant insights into the regulatory mechanisms underlying tissue and organ regeneration in these species [17] [18] [19] but morphological, physiological, and genetic differences between these species and mammals limit the translational potential for application to human disease. They do, however, provide the basis of the molecular investigations in mammals. 19 In mice, the role of individual microRNAs (miRNAs) and protein-coding messenger RNAs (mRNAs) have been defined by genetic analyses and gene targeting of specified mRNAs and miRNAs. 16, 20, 21 More recently with recognition of the functions of other RNA species, certain long noncoding RNAs (lncRNAs) have been implicated in cardiac biology, 22 for example, in protection from cardiac hypertrophy, fetal heart development, and autophagic cell death in MI. [23] [24] [25] [26] Although previous genome-wide studies have examined the coding transcriptome in neonatal and regenerating heart after apical resection, 27 genomewide changes in the noncoding transcriptome have not been reported.
Here, we have performed an in-depth analysis of the coding and noncoding mouse LV transcriptome by RNA sequencing at key time points in early postnatal mouse heart development and in the LV during the period of regeneration after neonatal ligation of the left anterior descending (LAD) coronary artery. The study defines the major sets of coding and noncoding RNAs associated with normal postnatal cardiac development and with regeneration of the neonatal heart after MI. We perform functional studies on a key set of exemplar miRNAs in mouse and human cardiomyocytes and identify conserved roles for these miRNAs in mammalian cardiomyocyte proliferation and mitosis. Our study provides new insights into the transcriptional regulation of neonatal cardiac development and regeneration in mammals that will be of value in future comparative and human intervention studies of cardiac regeneration.
Clinical Perspective
Coronary heart disease is among the commonest causes of death worldwide. After myocardial infarction, damaged myocardium in adult mammals is replaced by scar tissue triggering cardiac remodeling and dysfunction. Although teleost fish and some amphibians can, throughout their lifespan, regrow large portions of their limbs and internal organs after injury or excision, including the heart, mammals have limited regenerative ability. Neonatal mice can regenerate their hearts in the first days of their life, though not in later life, but the precise mechanisms are unclear. To investigate the regulators of mammalian heart regeneration, we performed an in-depth analysis of the coding and noncoding mouse left ventricle transcriptome at key time points in early postnatal mouse heart development and during the period of regeneration after neonatal myocardial infarction. These data defined the major sets of differentially expressed RNAs during normal postnatal cardiac development and after postneonatal myocardial infarction. We then demonstrated the regulatory role for key subsets of these miRNAs in cardiomyocyte proliferation and mitosis, both in mouse cardiomyocytes and in human induced pluripotent stem cell-derived cardiomyocytes. The sets of messenger RNAs, micro RNAs, and long noncoding RNAs that we report merit further investigation as gatekeepers of cell division in the postnatal heart, providing new insights into the functions of noncoding RNAs and a valuable resource for further experimentation in regenerative medicine. The in vivo manipulation of these RNAs could potentially lead to extension of the period of mammalian cardiac regeneration beyond the neonatal period.
MATERIALS AND METHODS
The data, analytic methods, and study materials have been made available to other researchers for purposes of reproducing the results or replicating the procedure. They have been made publicly available at the Annotare, accession number E-MTAB-6272. All animal experiments were performed in accordance with the Austrian Ethical Board, the Imperial College and the UK Home Office guidelines.
LAD artery ligation was performed in P0.5 neonatal C57BL6J mice, as previously described [15] . LV was harvested from 3 C57BL6J mice from sham-operated and LAD-ligated animals at 3-, 5-, 7-and 10-days post ligation. LV was also harvested from 3 C57BL6J mice at P1, P3, P5, P7, P10 (referred to as physiological time points) in which no surgical procedures had been performed. Coding and noncoding RNA-Seq libraries were prepared using Illumina TruSeq stranded RNA library preparation and TruSeq small RNA library preparation kits following manufacturers' protocols. Mouse genome assembly GCRm38/mm10 and the Ensembl transcript annotations (version GRCm38.87) were used as the reference sequence in all the analyses. RNA-Seq reads were quantified using Salmon (v 0.8.2). 28 Differential expression (DE) analysis was performed using DESeq2 Bioconductor package. Raw P values were adjusted for multiple testing with the Benjamini-Hochberg procedure. Weighted gene coexpression cluster analysis and a short timer series expression miner (STEM) analysis were performed to identify clusters of coexpressed mRNAs. Enrichment of Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways for DE mRNAs was calculated using DAVID (v6.8) across all pairwise comparisons. miRNA-Seq reads were aligned with Bowtie and MirDeep2 was used to determine the presence and quantity of miRNAs based on mouse precursor sequences and mature sequences from mouse and rat with miRBase release 19. miRNA binding sites were predicted in silico across each gene using the union of 5 separate prediction methods. Correlation matrices were generated between mRNAs and miRNAs and between mRNAs and lncRNAs. Potential functional relationships were identified by Spearman correlation, adjusted for multiple testing correction at false discovery rate<0.05. P5 mouse cardiomyocytes were treated with mmu-miR-22-5p, mmu-miR-144, mmu-miR-148a-3p, mmu-miR-193a-3p, mmu-miR-193b-3p, mmu-miR-221-3p, mmu-miR-331-3p, mmu-miR-451a inhibitors, and mmu-miR-6240 mimic and iCell cardiomyocytes were treated with human analogues of these miRs. Cells were incubated 10 μmol/L EdU 4 hours after seeding and subsequently fixed with 4% paraformaldehyde and permeabilized in 0.2% (v/v) Triton X-100 before incubation with Click-iT reaction. Hoechst was used for nuclear staining and pH3 to mark mitotic cells. The analysis was then performed with conventional epifluorescence microscopy.
RESULTS
To define the transcriptional changes occurring during physiological postnatal cardiac development and after neonatal MI, we generated RNA-Seq expression data of the coding and noncoding transcriptome from triplicate LV tissue harvested from C57BL/6 mice on postnatal day 0.5, 3.5, 5.5, 7.5, and 10.5, referred to as P1, P3, P5, P7, and P10, and from LV at 3 to 10 days after LAD ligation ( Figure 1 ).
Transcriptional Changes in Coding RNA
During the time course of physiological postnatal growth from P1 to P10, we identified 9450 unique differentially expressed mRNAs across all possible pairwise comparisons (Table I in the Data Supplement).
We identified an increase in gene expression of 11 cardiomyocyte markers at different time points and an increase in cardiac fibroblast marker (Ddr2) after P5, reflecting the change in cellular composition within the LV ( Figure I in the Data Supplement). Weighted gene coexpression cluster analysis and STEM analyses of these genes identified clusters enriched for focal adhesion (P-adj=1.22E-13), DNA replication (P-adj=5.47E-16), ribosome (P-adj=1.64E-50), and oxidative phosphorylation (OXPHOS) (P-adj=0.013) pathways of KEGG analysis ( Figure IIA and IIB in the Data Supplement). These results were affirmed in pairwise comparisons between time points, with enrichment for DNA replication genes between P1 and P5, oxidative phosphorylation, focal adhesion genes between P3 and P10, and ribosomal transcripts throughout a 10-day period ( Figure 2A ; Table  II STEM analysis of the post-LAD ligation data showed 15 statistically significant profiles of changing gene expression, which had generally decreasing gene expression related to immune processes such as phagosome (P-adj=5.9E-9) and cytokine-cytokine receptor interaction (P-adj=8.77E-8; Figure IIC in the Data Supplement).
Four profiles (40, 42, 48, and 49) showed increasing gene expression pattern and were significantly enriched for OXPHOS which was also observed in the weighted gene coexpression cluster analysis analysis ( Figure IIC and IID in the Data Supplement). STEM analysis of mRNA expression in the sham-operated mice (P3-P10) showed pathway enrichment for 13 profiles, mirroring enrichments observed in the physiological samples.
Consistent with the STEM annotation analysis, pairwise comparisons of the sham and LAD data at P3 showed that the major classes of DEG between P3 sham and LAD were within OXPHOS and lysosome pathways ( Figure 2E ; Table IV in the Data Supplement). Of the top 40 most significant DE mRNAs, we identified 5 genes (Fn1, Col1a1, Tnc, Thbs1, and Col1a2) with an increase in expression between sham and LAD at P3 that are implicated in focal adhesion pathways and 3 genes (Cd68, Laptm5, and Atp6v0d2) representing lysosome pathways ( Figure 2E and 2F) . Strikingly, 74% of the 3210 genes that were DE between sham and LAD were also DE in the pairwise comparisons in the normal physiological data ( Figure 2G ). Of the 10 284 DEG, 20 were validated and further characterized by quantitative polymerase chain reaction across all conditions used in the study using an independent set of triplicate samples ( Figure IVA in the Data Supplement).
Changes in Noncoding RNA Transcriptome
Next, we analyzed changes in the expression of noncoding RNAs including lncRNAs and miRNAs in the normal developing heart. Between all pairwise time point comparisons from P1 to P10, we identified 545 unique DE lncRNAs (Table I in the Data Supplement). A 4-fold increase in the number of DE lncRNAs was observed between P3 and P5 (n=24) and between P5 and P7 (n=107) comparisons ( Figure 3A ). Only 59 of 545 DE lncRNAs have assigned names, for the remainder, there has been limited, functional characterization. Four DE lncRNAs between P5vP7, within the top 40 DE, that have names and functions associated with them include: Nespas, Sorbs2os, H19, and Lockd ( Figure 3B ; Table I in the Data Supplement). This is the first report showing DE of any of these lncRNAs in the postnatal mammalian heart.
To explore potential interactions between lncRNAs and mRNAs in the developing heart, we tested for correlation between lncRNA and mRNA expression across P1 to P10 time points. Of the 545 DE lncRNAs, 491 correlated significantly (P-adj Spearman <0.05) with between 1 and 2604 mRNAs either in cis or trans. Overall, we found that there were slightly more (median=26) lncRNAs significantly correlating in trans compared with in cis (median=15), implying that their regulatory potential is not limited by chromosomal location ( Figure 3C ).
To determine possible functional regulatory roles of DE lncRNAs, we performed a KEGG analysis on the sets of genes correlating in cis or trans with DE lncRNAs. We identified 86 lncRNAs that correlated significantly with gene sets enriched for the ribosome pathway, 113 for oxidative phosphorylation, and 103 with enrichment for the focal adhesion pathway (Table III in Figure 3E) . A selection of these lncRNAs was significantly correlated with gene sets enriched in ribosome, OXPHOS, focal adhesion, lysosome, and phagosome KEGG pathways (Table  III in Table IV in the Data Supplement). The marked transition in expression of these miRNAs, between P3 and P5, has not previously been observed.
To identify the potential roles of DE miRNAs during the P1 to P10 time period, we examined the correlation between the 413 miRNAs that were DE between all the time points and all mRNAs expressed in these samples, and intersected these data with the in silico predicted binding partners of the DE miRNAs to give a set of RNAs that correlate with and may be targeted by these miRNAs (Figure V in the Data Supplement).
We identified 65 unique miRNAs where their significantly correlated gene targets are enriched for specific KEGG pathways, 34 of which target a total of 67 genes associated with the focal adhesion pathway (Table V in the Data Supplement). Interestingly, orthologs of 49 of these 65 miRNAs were also identified in the human genome and these showed conservation of gene targets for a median of 84% of the orthologous genes within the human pathways (Table V in the Data Supplement).
We also investigated the temporal relationship between miRNAs and mRNAs. The 240 DE miRNAs, identified between P3 and P5, are predicted to target 2731 mRNAs. Of these mRNAs, we observed a significant overlap with 222 of 494 of DE mRNAs between P3 and P5 (odds ratio=2.09; P=7.51e-15) and 1091 of the 3545 DE mRNAs between P5 and P7 (odds ratio=1.18; P=3.79e-4).
Small RNA-seq analysis showed 153 DE miRNAs between sham and LAD 3 days post ligation, followed by a marked decline in the number of DE miRNAs between sham and LAD at later time points ( Figure 4D 
2e-16).
Of the 39 DE miRNAs that correlated with and have predicted targets among the DE mRNAs, 14 miRNAs target gene sets of between 9 and 314 genes in pathways for cancer, and 14 miRNAs target between 13 and 23 mRNAs in focal adhesion ( Figure 4E ; Table V in the Data Supplement). Interestingly, 31 of 39 miRNAs were conserved in humans and targeted a median of 75.7% of the orthologous genes in corresponding human pathways. Mirroring the mRNA data, 83% of the miRNAs that were DE between sham and LAD were also DE in the pairwise comparisons between the physiological time points (Figure 4F ).
Functional Analysis of miR Inhibition and Overexpression in P5 Mouse Cardiomyocytes
To test the functional effects of miRNAs on cardiomyocyte proliferation, we performed inhibition and overexpression studies in mouse and human cardiomyocytes, on a set of miRNAs that exhibited significant changes in physiological and pathological conditions and correlated with changes in mRNA in focal adhesion pathway. We obtained over 80% reduction of the expression of 9 miRNAs in primary mouse cardiomyocytes and a subset of 4 of their human orthologs in iCell cardiomyocytes, and over 50% overexpression of miR-6240 (data not shown). Quantitative reverse transcription-polymerase chain reaction analysis of the expression of cell cycle-regulating cyclins revealed that the levels of Ccna2, CcnD2, and CcnE2 increased significantly (>2-fold) after treatment with miR-22-5p, miR451a, and miR-195a inhibitors, and with miR-6240 mimic, in comparison to cells treated with scramble (P<0.05; Figure 5A) . Treatment with 7 other miR inhibitors did not result in any significant changes (P>0.05) of tested cyclins expression ( Figure 5A ). Expression of Ccna1, CcnD1, CcnD3, and CcnE1 did not change in response to inhibition or overexpression of any of the miRNAs.
To determine whether inhibition or overexpression of these miRs plays a direct role in promoting cardiomyocyte proliferation, we measured the nuclear incorporation of EdU (S-phase marker) and pH3 staining (mitosis marker) in P5 mouse cardiomyocytes. A marked increase in proliferating (EdU positive) cells (up to 5-fold) was observed for cardiomyocytes treated with miR-22-5p, miR-144-3p, miR-148a-3p, miR-193a-3p, miR-193b-3p, miR-195a-5p, miR-221-3p, miR-331-3p, miR-451a inhibitors, and miR-6240 mimic ( Figure 5B ). Likewise, an increase of mitotic (pH3 positive) cells was seen (up to 3-fold), after treatment with miR-22-5p, miR-195a-5p, and miR-451a inhibitors and miR-6240 mimic ( Figure 5C ; Figure VIA in the Data Supplement). Scramble-treated mouse cells served as the negative control for both assays.
Functional Analysis of Selected miRs in Human Cardiomyocytes
Given our data showing that several miRNAs regulate aspects of proliferation in P5 mouse cardiomyocytes, we tested whether the human orthologs of these miRNAs can functionally regulate cardiomyocyte proliferation in iCell cardiomyocytes. We transfected iCell cardiomyocytes with a subset of human miR inhibitor and mimic orthologs that we had previously tested in mouse cardiomyocytes. Quantitative reverse transcription-polymerase chain reaction analysis of cyclins expression revealed elevated levels of Ccna2, CcnD2, and CcnE2 in miR-22-5p, miR-451a, and miR-6240 treated cells in comparison with scramble treatment (P<0.05; Figure 5D ). As with the mouse miR interventions, levels of Ccna1, CcnD1, CcnD3, and CcnE1 were unchanged ( Figure 5D ). iCell cardiomyocytes treatment with miR-6240 mimic showed an increase in number of proliferating cells and treatment with miR-144-3p, miR-195a-5p, miR-451a, and miR-6240 showed up to a 2-fold increase in the number of mitotic cells (Figure 5E and 5F; Figure VIB in the Data Supplement).
DISCUSSION
We set out to define the program of the coding and noncoding transcriptome in the healthy neonatal heart during the period of loss of regenerative capacity and to relate this to the transcriptional changes associated with cardiac regeneration after neonatal MI. We found a sharp transition in miRNA expression in the developing heart between P3 and P5 associated with subsequent changes in expression of genes on the focal adhesion pathway and cardiomyocyte division arrest. We mapped profound changes in the transcriptome that returned to normal within 10 days after neonatal MI, indicating essentially complete healing of the myocardium by this time point, confirming our previous findings. 15 We showed that twothirds of all RNA species that were DE in the post-MI heart were also DE during normal postnatal development, suggesting a common regulatory pathway for normal postnatal cardiac development and post-MI regeneration. Finally, we demonstrated that miR-144-3p, miR-195a-5p and miR-451a inhibition, and miR-6240 activation have functionally conserved roles in cell proliferation and mitosis in mouse and human cardiomyocytes.
We found that the first 10 days of postnatal life were associated with alterations in gene expression of thousands of genes, particularly those encoding proteins involved in cell cycle progression at early time points, oxidative phosphorylation at later time points and protein translation throughout. These enriched pathways are likely reflective of changes in ventricular pressure, transition from hypoxic to the oxygen rich postnatal environment with increased reliance on oxidative metabolism, and changes in cellular architecture and the extracellular matrix between P3 and P7. 13, 29 During the P5 and P7 time window, one-quarter of the most DEG correspond to gene ontology terms associated with M-phase mitosis and mitotic cell cycle checkpoint, including Cdk1, 30 Ccna2, 31 Cdc13, 32 and Bub1, 33 in keeping with the withdrawal of cardiomyocytes from DNA replication and cell division at this time point. Although the relative abundance of myocytes, cardiac fibroblasts, endothelial cells, and vascular smooth muscle cells change in the LV during the first 10 postnatal days 34 and ontologies and pathways identified through our transcriptomic study are in part reflective of this, we were able to identify putative drivers of cardiomyocyte proliferation and functionally validate them in mouse primary cells and human cardiomyocyte cell line.
We found major differences in mRNA, miRNA, and lncRNA expression between LAD-ligated and shamoperated mice 3 days after MI, but these differences had almost completely resolved within 7 days of LAD ligation and increased gene expression of cardiomyocyte markers is restored to mirror closely the physiological gene expression changes. At the transcriptional level, therefore, the regenerative process was essentially complete by P10, although certain developmental and cardiac failure markers, like Nppa, 35 remained elevated. The most profoundly DEG 3 days post-LAD were those involved in immune processes, similarly shown in the contrasting model of heart regeneration after apex removal together with cell cycle progression and RNA synthesis 27 and oxidative phosphorylation, in keeping with previous observations of the importance of an active immune response in physiological regulation of cardiac regeneration in mice. 36, 37 Similar changes in expression were observed with lncRNAs, where of the 107 DE lncRNAs between P5 and P7, only 7, including H19 and Neat1, have proposed functions, in cell proliferation, [38] [39] [40] and none have been previously associated with postnatal heart development or regeneration. We also found evidence for transregulation of expression by lncRNAs with enrichment among correlating gene sets on OXPHOS, ribosomes, and focal adhesion pathways, and show significant enrichment for imprinting among DE lncRNAs. Although previously described in other tissues, 41 enrichment for imprinted loci has rarely been observed previously in the postnatal heart or after MI. 42 We observed a profound shift in miRNA expression in the developing heart between P3 and P5 associated with an altered expression of genes on the focal adhesion pathway between P5 and P7. Because genes and proteins on the focal adhesion pathway mediate the transduction of external stimuli such as increasing blood pressure or hypoxia 29, 43, 44 into processes such as DNA replication and cell division, 45 we hypothesize that the set of miRNAs that were DE in the P3 to P5 time window are key to the regulation of molecular events leading to withdrawal of the cardiomyocyte from cell division in the first week of life. To test this hypothesis, we performed in vitro inhibition and overexpression studies on 10 miRNAs which exhibited significant changes in physiological and pathological conditions. They include 2 miRNAs (miR-195a-5p and miR-22-5p) for which previous evidence has been presented. 20, 46 Our results demonstrate that the inhibition of miR-22-5p and miR-451a and miR-6240 upregulation individually elevate the expression of CcnA2, CcnD2, and CcnE2 in P5 mouse and human cardiomyocytes leading to increased proliferation and cell division. We did not observe changes in expression of CcnA1 (expressed in germ cells), CcnE1 (lowly expressed in heart), CcnD1, or CcnD3 (low expression in tested cardiomyocytes) in comparison to scramble-treated cells. Targets of miR-22 include Map2k1, Map3k9, Rock2 representing the focal adhesion pathway, regulation of cell proliferation, and Aurkb participating in the regulation of alignment and segregation of chromosomes during cell division. 47 miR-451a targets Tbx1 and Ybx1 transcription factors regulating proliferation and differentiation of multipotent heart progenitors 48 and is implicated in translational control of fetal myocardial gene expression after cardiac transplant. 49 There is limited knowledge on the functional role of miR-6240, and here we show for the first time, its function in cardiomyocyte proliferation and heart regeneration in mouse and human cardiomyocytes. 50 Interestingly, miR-22 has been previously found to be highly expressed in cardiac muscle, upregulated during myocyte differentiation which alone has been found to be sufficient to induce cardiomyocyte hypertrophy.
Our study reports the transcriptional changes in the developing and post-MI postnatal heart and defines sets of mRNAs, miRNAs, and lncRNAs that we propose to be the key regulators, at the level of the transcriptome, of withdrawal of the postnatal mouse heart from DNA replication and cell division. We also identify miR-144-3p, miR-195a, miR-451a, and miR-6240 as functionally conserved, noncoding regulators of cardiomyocyte division in neonatal mouse and humans. Although we have not studied all the downstream consequences of our findings, including more detailed impact on protein, cell cycle, and in vivo validation, our work provides a platform for future studies.
Recent progress in research in developmental cardiology has significantly advanced our understanding of heart development and regeneration. 51 Insights from zebrafish models of heart regeneration, after apex removal or cryosurgery, show that they are capable of myocardial regeneration mediated mainly through the proliferation of preexisting gata4 + cardiomyocytes with miR-133 52 and miR-101, 53 playing regulatory roles in this process, as also shown in our neonatal mouse data set. More recently, the attempt to pinpoint the regulatory hubs in zebrafish heart regeneration revealed a function of il6st, adam8, and cd63, 19 also shown to be DE expressed in our postligation data sets. Studies of heart regeneration in neonatal mice reported Myh7 and Igf1r as key drivers of gene interaction networks and pointing to C1orf61, Aif1, Rock1 as potential inhibitors of cardiomyocyte proliferation and G1/S phase transition, 54 genes that were also DE between physiological time points in our set. In addition, miRNAs from the miR-15 family, 20 miR-503-5p, 54 miR-199a, 55 miR-99/100, and Let7a/c 21 were also reported as critical regulators of the regeneration process, which were also found as DE in our physiological and sham/LAD comparisons in our data set. Interleukin-13, DE in the regenerating neonatal heart in our data set, has also been identified as a regulator of cardiomyocyte cell cycle entry mediated by STAT3/periostin and STAT6. 27 Although our data show considerable overlap with previous observations in mice and zebrafish, we provide a systematic and comprehensive analysis of coding and noncoding transcriptome changes over multiple time points of the first 10 days of postnatal life and after neonatal LAD ligation, which has not been available hitherto.
In summary, we present a finely grained time course for mRNA, miRNA, and lncRNA in the normal developing heart from postnatal day 1 (P1) to P10, and in the 3 to 10 days after neonatal MI. We found profound changes in the coding and noncoding transcriptome after neonatal MI, with evidence of essentially complete transcriptional healing by P10. We find a sharp transition in miRNA expression in physiological cardiac samples between P3 and P5, with differentially expressed miRNAs associated specifically with altered expression of genes on the focal adhesion pathway and cessation of cardiomyocyte division. Two-thirds of each of the mRNAs, lncRNAs, and miRNAs that were differentially expressed in the post-MI heart were also differentially expressed during normal postnatal development, suggesting a common regulatory pathway for normal cardiac development and post-MI cardiac regeneration. Of the miRNAs that we implicate in regulation of cardiomyocyte development and regeneration, 67% had targets that were conserved between mice and humans. We present a subset of miRNAs: miR-451a, miR-6240, miR-195a-5p, and miR-144-3p that showed functional evidence in vitro as regulators of cell division in mouse and human cardiomyocytes.
